Table 3.
Baseline Work Productivity and Activity Index for Spondyloarthritis scores for tumor necrosis factor inhibitor-experienced patients (COAST-W study) across treatment arms
| Work productivity and activity measures | Treatment arms | ||
|---|---|---|---|
| PBO (N = 104) | IXE Q4W (N = 114) | IXE Q2W (N = 98) | |
| Absenteeisma | |||
| Nx | 60 | 56 | 51 |
| Mean (SD) | 14.6 (22.0) | 22.9 (33.2) | 16.8 (25.3) |
| Presenteeisma | |||
| Nx | 59 | 50 | 48 |
| Mean (SD) | 58.8 (24.5) | 60.0 (19.7) | 63.8 (16.1) |
| Overall work impairmenta | |||
| Nx | 59 | 50 | 48 |
| Mean (SD) | 62.3 (25.7) | 64.0 (20.8) | 67.5 (16.0) |
| Activity impairment | |||
| Nx | 104 | 114 | 98 |
| Mean (SD) | 67.5 (20.1) | 72.5 (19.6) | 72.0 (17.6) |
N Number of patients in the treatment group, Nx number of patients in the analysis subgroup
aAbsenteeism, presenteeism, and overall work impairment were measured in patients reporting part- or full-time work